Skip to main content
SpringerLink
Log in

Drug-drug interaction potential of Janus kinase inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Veeravalli V, et al. Critical Assessment of Pharmacokinetic Drug-Drug Interaction Potential of Tofacitinib, Baricitinib and Upadacitinib, the Three Approved Janus Kinase Inhibitors for Rheumatoid Arthritis Treatment. Drug Safety : 4 May 2020. Available from: URL: http://doi.org/10.1007/s40264-020-00938-z

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Drug-drug interaction potential of Janus kinase inhibitors. Reactions Weekly 1804, 9 (2020). https://doi.org/10.1007/s40278-020-78438-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-78438-3

Search

Navigation